USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Daio Paper Corporation

USPTO PatentsView assignee record - 309 granted patents across 60 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Daio ranks #1,357 of 49,997 tracked US assignees by granted-patent volume, with 309 patents across 60 technology areas.

#1,357
of 49,997 US assignees by volume
Top 5%
by Innovation Score (57.5/100)
7.4
avg claims per patent
+267%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1357 · Foreign Corporation #1,357 · 309 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 309 grants
  • TOP-DECILE #1,357/49,997
  • PHOTO-FINISH Advanced Bionics
  • CPC-WIDE A61F · 60 areas
  • INNOV-PAR 57.5/100
  • CLAIMS-SPARSE 7.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +267% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Advanced Bionics AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Daio

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Daio's Innovation Score is 57.5/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Daio's grant cadence moved

Between 2020–2024, Daio Paper Corporation received 220 grants versus 60 in 2015–2019 (+267% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2022 at 74 grants and bottomed in 2016 at 4. Lead class A61F accounts for 58.6% of the portfolio across 60 subclasses. Volume neighbours: CGG Services SAS (#1,353) and Shanghai Jiao Tong University (#1,361).

Daio's three-year grant acceleration

From 2019–2021 to 2022–2024, Daio Paper Corporation moved from 109 to 134 grants (1.23x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #738. See the growth leaderboard.

Who files at Daio's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Daio holds 309 patents at rank #1,357, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Daio

By rank, the assignees closest to #1,357 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Daio's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Daio, neither rank-band nor same-CPC leaders (those blocks stay above).

Daio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

020406080 20152016201720182019202020212022202320242025 29
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Daio Paper Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 11 3.6%
2016 4 1.3%
2017 9 2.9%
2018 13 4.2%
2019 23 7.4%
2020 31 10.0%
2021 55 17.8%
2022 74 23.9%
2023 28 9.1%
2024 32 10.4%
2025partial year 29 9.4%

Which technologies does Daio Paper Corporation patent most?

Top 15 of 60 technology areas

Where it ranks

Overall rank by patents

#1,357

of 49,997 tracked assignees

Innovation Score

57.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Daio Paper Corporation's patent record in context - here's where to go next.

  • Daio Paper Corporation's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 58.6% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #1,357 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Daio Paper Corporation against CGG Services SAS, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 57.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.